Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis

by Ren-qi Yao, Ren-qi Yao, De-meng Xia, Li-xue Wang, Guo-sheng Wu, Yi-bing Zhu, Hong-qiang Zhao, Qi Liu, Zhao-fan Xia, Chao Ren, Yong-ming Yao
Published 2020-05-01

Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials

by Lei Zhong, Xiao-Wei Ji, Hai-Li Wang, Guang-Ming Zhao, Qing Zhou, Bo Xie
Published 2020-10-01

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

by James A. Russell, Jean-Louis Vincent, Anne Louise Kjølbye, Håkan Olsson, Allan Blemings, Herbert Spapen, Peder Carl, Pierre-Francois Laterre, Lars Grundemar
Published 2017-08-01